海兔素對人肝癌細胞及小鼠肝癌移植瘤抑制作用的研究
發(fā)布時間：2018-09-18 16:39
【摘要】：目的:本實驗通過觀察海兔素對人肝癌Hep G2細胞株增殖以及對小鼠H22肝癌移植瘤的抑制效應,以此探討海兔素對肝癌的抑制作用及可能的分子機制。方法:1.人肝癌Hep G2細胞株常規(guī)培養(yǎng)于含10%胎牛血清的DMEM/HIGH GLUCOSE完全培養(yǎng)基,置于37℃、體積分數(shù)為0.05 CO2的細胞恒溫培養(yǎng)箱中培養(yǎng)。取對數(shù)生長期細胞,分別加入終末濃度為20、40、60、80、100、120mg/L的海兔素溶解液對其進行干預,Cell Counting Kit-8(CCK-8)法檢測海兔素作用24h、48h后對肝癌Hep G2細胞株增殖的影響;熒光顯微鏡Annexin V-FITC/PI雙染實驗檢測海兔素對Hep G2肝癌細胞株凋亡的誘導作用。2.昆明種雄性小鼠40只,將其按體重隨機分為模型組和海兔素低、中、高劑量組,每組10只。將以生理鹽水稀釋的H22瘤細胞懸液接種于各組小鼠左前肢腋下皮下組織,建立小鼠H22皮下移植瘤模型。次日,海兔素低、中、高劑量組分別給予海兔素25、50、100mg·kg-1·d-1 0.5m L灌胃;模型組動物則予以等體積大豆色拉油灌胃,實驗進行2周。小鼠末次灌胃24h后,稱取體質量,摘眼球法取全血,頸椎脫臼法處死動物。完整剝離新鮮移植瘤組織,稱重,計算抑瘤率;免疫組化法檢測腫瘤組織中基質金屬蛋白酶-9(MMP-9)、血管內皮生長因子(VEGF)及增殖細胞核抗原(PCNA)的表達情況;酶聯(lián)免疫吸附試驗(ELISA法)測定小鼠血清中白介素6(IL-6)和腫瘤壞死因子α(TNF-α)的含量。結果:1.海兔素對人肝癌Hep G2細胞株抑制作用的體外試驗效果評價CCK-8實驗結果表明,Hep G2肝癌細胞經海兔素干預后,生長增殖能力顯著受到抑制,且隨藥物劑量的增加和干預時間的延長,抑制作用增強(P0.05),其24h IC25值和IC50值分別為65.36mg/L和103.77mg/L。熒光顯微鏡Annexin V-FITC/I雙染實驗檢測發(fā)現(xiàn),經65mg/L和105mg/L海兔素干預24h后,Hep G2肝癌細胞凋亡數(shù)目較對照組明顯增加,差異均具有統(tǒng)計學意義(P0.05)。2.海兔素對H22荷瘤小鼠體內抑瘤試驗效果評價H22荷瘤小鼠經低、中、高劑量海兔素處理后,腫瘤的生長水平顯著受到抑制,與模型組相比,瘤塊質量呈劑量依賴性顯著減輕(P0.05),其抑瘤率分別為28.31%、33.84%、42.96%。海兔素各劑量干預組小鼠移植瘤組織中MMP-9的陽性表達率與模型組相比,均有不同程度地降低,尤其是50mg/kg、100mg/kg劑量組降低更為明顯,差異具有統(tǒng)計學意義(P0.05);各海兔素組與模型動物組相比,小鼠腫瘤組織中VEGF和PCNA的陽性表達率逐漸降低,并呈一定的劑量依賴關系(P0.05)。經50mg/kg、100mg/kg海兔素處理后,小鼠血清中IL-6及TNF-α表達水平均顯著高于模型組,差異具有統(tǒng)計學意義(P0.05)。結論:1.通過體外細胞培養(yǎng)的方法,運用CCK-8法及熒光顯微鏡Annexin V-FITC/PI雙染實驗法,初步證實了海兔素能夠有效抑制肝癌細胞的增殖作用,同時顯著誘導肝癌細胞發(fā)生凋亡。2.海兔素能夠在體內抑制小鼠H22肝癌移植瘤的生長,其作用機制主要表現(xiàn)為以下幾個方面:①抑制腫瘤組織周圍細胞外基質降解過程②阻礙新血管形成過程③提高機體免疫功能。3.體內、外研究結果顯示,海兔素對肝癌具有明顯的抑制作用,有望成為一種新型的天然抗癌藥物。然而海兔素能否成為有效逆轉和治療肝癌的藥物,尚需要進一步的實驗研究進行佐證。
[Abstract]:OBJECTIVE: To investigate the inhibitory effect of pirarin on the proliferation of human hepatocellular carcinoma Hep G2 cell line and H22 transplanted tumor in mice, and to explore the possible molecular mechanism of pirarin on hepatocellular carcinoma. Methods: 1. The human hepatocellular carcinoma Hep G2 cell line was cultured in DMEM / HIGH GLUCOSE complete medium containing 10% fetal bovine serum and placed in 37% medium. Cells in logarithmic growth phase were cultured in a constant temperature incubator with 0.05 CO2 volume fraction and 20,40,60,80,100,120 mg/L Kainin solution respectively. Cell Counting Kit-8 (CCK-8) assay was used to detect the effect of Kainin on proliferation of Hep G2 cell line after 24 hours and 48 hours. V-FITC/PI double staining assay was used to detect the induction of apoptosis of Hep G2 hepatoma cell line. 2. Forty Kunming male mice were randomly divided into two groups according to their body weight: model group and low, medium and high dosage groups, 10 in each group. The next day, the mice were given 25,50,100 mg kg 1 D 10.5 ml of kaempferol by gastric lavage respectively, and the mice in the model group were given soybean salad oil by gastric lavage for 2 weeks. After 24 hours of the last gastric lavage, the mice were weighed, eyeballs were taken out, and the animals were killed by cervical vertebra dislocation. The expression of matrix metalloproteinase-9 (MMP-9), vascular endothelial growth factor (VEGF) and proliferating cell nuclear antigen (PCNA) in tumor tissues were detected by immunohistochemistry, and the levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) in serum of mice were determined by enzyme linked immunosorbent assay (ELISA). The results of CCK-8 assay showed that the growth and proliferation of Hep G2 hepatoma cells were significantly inhibited after the intervention of kaempferol, and the inhibition increased with the increase of drug dosage and the prolongation of intervention time (P 0.05). The 24-hour IC25 and IC50 values of Hep G2 hepatoma cells were 65.36 m, respectively. G/L and 103.77 mg/L. Fluorescence microscope Annexin V-FITC/I double staining assay found that after 65 mg/L and 105 mg/L kaempferol intervention for 24 hours, the number of apoptosis of Hep G2 hepatoma cells was significantly increased compared with the control group, the difference was statistically significant (P 0.05). 2. Compared with the model group, the tumor growth level was significantly inhibited, and the tumor mass was significantly reduced in a dose-dependent manner (P 0.05). The tumor inhibition rates were 28.31%, 33.84% and 42.96% respectively. The positive expression rates of VEGF and PCNA in tumor tissues of mice were gradually decreased and showed a dose-dependent relationship (P 0.05). After treatment with 50 mg/kg and 100 mg/kg Haituansu, the expression of IL-6 and TNF-alpha in serum of mice was significantly decreased (P 0.05). CONCLUSION: 1. The CCK-8 method and fluorescence microscope Annexin V-FITC/PI double staining method were used in vitro cell culture, and the preliminary results showed that pikacin could effectively inhibit the proliferation of hepatocellular carcinoma cells and induce apoptosis of hepatocellular carcinoma cells. It can inhibit the growth of H22 liver cancer xenograft tumor in vivo. The main mechanisms are as follows: 1. Inhibiting the degradation of extracellular matrix around tumor tissue; 2. Inhibiting the formation of new blood vessels; 3. In vivo and in vitro studies show that hippocampin has a significant inhibitory effect on liver cancer. It is expected to become a new natural anticancer drug. However, further experimental studies are needed to confirm whether kaempferol can be an effective drug for reversing and treating liver cancer.
【學位授予單位】：青島大學
【學位級別】：碩士
【學位授予年份】：2015
【分類號】：R735.7
本文編號：2248504
[Abstract]:OBJECTIVE: To investigate the inhibitory effect of pirarin on the proliferation of human hepatocellular carcinoma Hep G2 cell line and H22 transplanted tumor in mice, and to explore the possible molecular mechanism of pirarin on hepatocellular carcinoma. Methods: 1. The human hepatocellular carcinoma Hep G2 cell line was cultured in DMEM / HIGH GLUCOSE complete medium containing 10% fetal bovine serum and placed in 37% medium. Cells in logarithmic growth phase were cultured in a constant temperature incubator with 0.05 CO2 volume fraction and 20,40,60,80,100,120 mg/L Kainin solution respectively. Cell Counting Kit-8 (CCK-8) assay was used to detect the effect of Kainin on proliferation of Hep G2 cell line after 24 hours and 48 hours. V-FITC/PI double staining assay was used to detect the induction of apoptosis of Hep G2 hepatoma cell line. 2. Forty Kunming male mice were randomly divided into two groups according to their body weight: model group and low, medium and high dosage groups, 10 in each group. The next day, the mice were given 25,50,100 mg kg 1 D 10.5 ml of kaempferol by gastric lavage respectively, and the mice in the model group were given soybean salad oil by gastric lavage for 2 weeks. After 24 hours of the last gastric lavage, the mice were weighed, eyeballs were taken out, and the animals were killed by cervical vertebra dislocation. The expression of matrix metalloproteinase-9 (MMP-9), vascular endothelial growth factor (VEGF) and proliferating cell nuclear antigen (PCNA) in tumor tissues were detected by immunohistochemistry, and the levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) in serum of mice were determined by enzyme linked immunosorbent assay (ELISA). The results of CCK-8 assay showed that the growth and proliferation of Hep G2 hepatoma cells were significantly inhibited after the intervention of kaempferol, and the inhibition increased with the increase of drug dosage and the prolongation of intervention time (P 0.05). The 24-hour IC25 and IC50 values of Hep G2 hepatoma cells were 65.36 m, respectively. G/L and 103.77 mg/L. Fluorescence microscope Annexin V-FITC/I double staining assay found that after 65 mg/L and 105 mg/L kaempferol intervention for 24 hours, the number of apoptosis of Hep G2 hepatoma cells was significantly increased compared with the control group, the difference was statistically significant (P 0.05). 2. Compared with the model group, the tumor growth level was significantly inhibited, and the tumor mass was significantly reduced in a dose-dependent manner (P 0.05). The tumor inhibition rates were 28.31%, 33.84% and 42.96% respectively. The positive expression rates of VEGF and PCNA in tumor tissues of mice were gradually decreased and showed a dose-dependent relationship (P 0.05). After treatment with 50 mg/kg and 100 mg/kg Haituansu, the expression of IL-6 and TNF-alpha in serum of mice was significantly decreased (P 0.05). CONCLUSION: 1. The CCK-8 method and fluorescence microscope Annexin V-FITC/PI double staining method were used in vitro cell culture, and the preliminary results showed that pikacin could effectively inhibit the proliferation of hepatocellular carcinoma cells and induce apoptosis of hepatocellular carcinoma cells. It can inhibit the growth of H22 liver cancer xenograft tumor in vivo. The main mechanisms are as follows: 1. Inhibiting the degradation of extracellular matrix around tumor tissue; 2. Inhibiting the formation of new blood vessels; 3. In vivo and in vitro studies show that hippocampin has a significant inhibitory effect on liver cancer. It is expected to become a new natural anticancer drug. However, further experimental studies are needed to confirm whether kaempferol can be an effective drug for reversing and treating liver cancer.
【學位授予單位】：青島大學
【學位級別】：碩士
【學位授予年份】：2015
【分類號】：R735.7
【相似文獻】
相關期刊論文 前7條
1 賀娟;梁惠;韓磊;馬愛國;孫永葉;;海兔素對人乳腺癌細胞增殖及血管內皮生長因子表達的影響[J];營養(yǎng)學報;2009年05期
2 賀娟;梁惠;李元;史大永;馬愛國;;海兔素對D-半乳糖誘導衰老小鼠抗氧化作用[J];中國公共衛(wèi)生;2009年09期
3 梁惠;劉穎;蘇愛;韓磊;馬愛國;;海兔素對體外人乳腺癌FCM-7細胞的抑制作用[J];營養(yǎng)學報;2013年06期
4 馬文龍;梁惠;劉穎;;海兔素對人乳腺癌SK-BR-3細胞的抑制作用及機制研究[J];天然產物研究與開發(fā);2012年09期
5 戈娜;梁惠;劉穎;宮安靜;王文成;;海兔素對慢性酒精性肝損傷大鼠肝超微結構及NO和iNOS的影響[J];中國海洋藥物;2014年03期
6 豐暖;梁惠;戈娜;劉穎;;海兔素對酒精性肝損傷大鼠Fas/FasL及TNF-α表達的影響[J];中國海洋藥物;2014年02期
7 ;[J];;年期
相關會議論文 前4條
1 賀娟;梁惠;史大永;馬愛國;;海兔素對D—半乳糖誘導的衰老小鼠抗氧化作用的實驗研究[A];中國營養(yǎng)學會第十次全國營養(yǎng)學術會議暨第七屆會員代表大會論文摘要匯編[C];2008年
2 賀娟;梁惠;史大永;馬愛國;;海兔素對D一半乳糖誘導的衰老小鼠抗氧化作用的實驗研究[A];中國營養(yǎng)學會第十次全國營養(yǎng)學術會議公共營養(yǎng)分會論文集[C];2008年
3 梁惠;張秀珍;賀娟;逄丹;馬愛國;;海兔素對D-半乳糖誘導的氧化損傷小鼠抗氧化作用的實驗研究[A];食物功效成分與健康——達能營養(yǎng)中心第九次學術年會會議論文集[C];2006年
4 梁惠;劉穎;韓磊;賀娟;馬愛國;;海兔素阻斷EGFR受體通路抑制乳腺癌細胞增殖并誘導凋亡作用研究[A];“細胞活動 生命活力”——中國細胞生物學學會全體會員代表大會暨第十二次學術大會論文摘要集[C];2011年
相關碩士學位論文 前2條
1 王青;海兔素對人肝癌細胞及小鼠肝癌移植瘤抑制作用的研究[D];青島大學;2015年
2 豐暖;海兔素在肝微粒體中酶動力學及對酒精損傷大鼠Fas/FasL、TNF-α表達影響研究[D];青島大學;2014年
，本文編號：2248504
本文鏈接：http://www.sikaile.net/yixuelunwen/zlx/2248504.html
最近更新
教材專著
